1. Home
  2. PLUS vs ARWR Comparison

PLUS vs ARWR Comparison

Compare PLUS & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUS
  • ARWR
  • Stock Information
  • Founded
  • PLUS 1990
  • ARWR 2003
  • Country
  • PLUS United States
  • ARWR United States
  • Employees
  • PLUS N/A
  • ARWR N/A
  • Industry
  • PLUS Retail: Computer Software & Peripheral Equipment
  • ARWR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLUS Technology
  • ARWR Health Care
  • Exchange
  • PLUS Nasdaq
  • ARWR Nasdaq
  • Market Cap
  • PLUS 1.9B
  • ARWR 1.8B
  • IPO Year
  • PLUS 1996
  • ARWR 1993
  • Fundamental
  • Price
  • PLUS $64.02
  • ARWR $16.31
  • Analyst Decision
  • PLUS
  • ARWR Buy
  • Analyst Count
  • PLUS 0
  • ARWR 8
  • Target Price
  • PLUS N/A
  • ARWR $43.71
  • AVG Volume (30 Days)
  • PLUS 138.3K
  • ARWR 2.0M
  • Earning Date
  • PLUS 08-07-2025
  • ARWR 08-07-2025
  • Dividend Yield
  • PLUS N/A
  • ARWR N/A
  • EPS Growth
  • PLUS N/A
  • ARWR N/A
  • EPS
  • PLUS 4.05
  • ARWR N/A
  • Revenue
  • PLUS $2,068,789,000.00
  • ARWR $545,209,000.00
  • Revenue This Year
  • PLUS $3.30
  • ARWR $22,384.93
  • Revenue Next Year
  • PLUS $2.29
  • ARWR N/A
  • P/E Ratio
  • PLUS $15.75
  • ARWR N/A
  • Revenue Growth
  • PLUS N/A
  • ARWR 1436.97
  • 52 Week Low
  • PLUS $53.83
  • ARWR $9.57
  • 52 Week High
  • PLUS $106.98
  • ARWR $27.34
  • Technical
  • Relative Strength Index (RSI)
  • PLUS 36.61
  • ARWR 49.44
  • Support Level
  • PLUS $62.11
  • ARWR $15.50
  • Resistance Level
  • PLUS $69.70
  • ARWR $16.63
  • Average True Range (ATR)
  • PLUS 1.85
  • ARWR 1.04
  • MACD
  • PLUS -0.46
  • ARWR -0.03
  • Stochastic Oscillator
  • PLUS 20.83
  • ARWR 40.00

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Share on Social Networks: